REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 30th November 2023 |
for |
Immunoclot Ltd |
REGISTERED NUMBER: |
Unaudited Financial Statements for the Year Ended 30th November 2023 |
for |
Immunoclot Ltd |
Immunoclot Ltd (Registered number: 05279113) |
Contents of the Financial Statements |
for the Year Ended 30th November 2023 |
Page |
Balance Sheet | 1 |
Notes to the Financial Statements | 2 |
Immunoclot Ltd (Registered number: 05279113) |
Balance Sheet |
30th November 2023 |
30.11.23 | 30.11.22 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors | 5 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 6 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 7 |
Retained earnings |
SHAREHOLDERS' FUNDS |
The director acknowledges his responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered. |
The financial statements were approved by the director and authorised for issue on |
Immunoclot Ltd (Registered number: 05279113) |
Notes to the Financial Statements |
for the Year Ended 30th November 2023 |
1. | COMPANY INFORMATION |
Immunoclot Ltd is a |
Registered number: |
Registered office: |
The presentation currency of the financial statements is the Pound Sterling (£). |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Tangible fixed assets |
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss. |
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis: |
Fixtures and Fittings - 25% on cost |
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss. |
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Going concern |
The company has received no income during the year due to IR35 regulation changes. However, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the year was |
Immunoclot Ltd (Registered number: 05279113) |
Notes to the Financial Statements - continued |
for the Year Ended 30th November 2023 |
4. | TANGIBLE FIXED ASSETS |
Fixtures |
and |
fittings |
£ |
COST |
At 1st December 2022 |
and 30th November 2023 |
DEPRECIATION |
At 1st December 2022 |
and 30th November 2023 |
NET BOOK VALUE |
At 30th November 2023 |
At 30th November 2022 |
5. | DEBTORS |
30.11.23 | 30.11.22 |
£ | £ |
Amounts falling due within one year: |
Other debtors |
Amounts falling due after more than one year: |
Other debtors |
Aggregate amounts |
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.11.23 | 30.11.22 |
£ | £ |
Tax |
Directors' current accounts | 6,749 | 6,204 |
7. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 30.11.23 | 30.11.22 |
value: | £ | £ |
Ordinary A | 1 | 50 | 50 |
Ordinary B | 1 | 49 | 49 |
99 | 99 |
The Ordinary A shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company. |
The Ordinary B shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company. |
The A and B shares rank pari passu in respect of dividend and capital distribution rights. |
Immunoclot Ltd (Registered number: 05279113) |
Notes to the Financial Statements - continued |
for the Year Ended 30th November 2023 |
8. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES |
The following advances and credits to a director subsisted during the years ended 30th November 2023 and 30th November 2022: |
30.11.23 | 30.11.22 |
£ | £ |
Balance outstanding at start of year | ( |
) | ( |
) |
Amounts repaid | ( |
) | ( |
) |
Amounts written off | - | - |
Amounts waived | - | - |
Balance outstanding at end of year | ( |
) | ( |
) |
The loan is repayable on demand and no interest was charged during the year. |
9. | CONTROL |
The ultimate controlling party is Dr P Ames by virtue of his 100% holding of the voting share capital. |